PTI. Pune based drugmaker has partnered with global pharma giant AstraZeneca to produce COVID-19 vaccine by University of Oxford for low-and-middle income countries.
Dubbed as Covishield, the COVID-19 vaccine is currently in the Phase III clinical trial in India. "We have received a confirmation about PM Modi's visit to the Serum Institute of India on Saturday, but his minute-to-minute program is yet to be received," Pune divisional commissioner Saurabh Rao told PTI.The prime minister earlier assured that the government is keeping a close watch on the development of vaccines and is in contact with Indian developers and manufacturers, along with global regulators, governments of other countries, multilateral institutions and international.
Read more on livemint.com